APA (7th ed.) Citation

M, A., MJ, S., C, M., K, T., K, T., GJ, v. G., . . . MBB, M. (2024). A Pfs48/45-based vaccine to block Plasmodium falciparum transmission: Phase 1, open-label, clinical trial. BMC medicine, 22(1), 170. https://doi.org/10.1186/s12916-024-03379-y

Chicago Style (17th ed.) Citation

M, Alkema, et al. "A Pfs48/45-based Vaccine to Block Plasmodium Falciparum Transmission: Phase 1, Open-label, Clinical Trial." BMC Medicine 22, no. 1 (2024): 170. https://doi.org/10.1186/s12916-024-03379-y.

MLA (9th ed.) Citation

M, Alkema, et al. "A Pfs48/45-based Vaccine to Block Plasmodium Falciparum Transmission: Phase 1, Open-label, Clinical Trial." BMC Medicine, vol. 22, no. 1, 2024, p. 170, https://doi.org/10.1186/s12916-024-03379-y.